Literature DB >> 8151778

Extensive envelope heterogeneity of simian immunodeficiency virus in tissues from infected macaques.

B J Campbell1, V M Hirsch.   

Abstract

The extent of virus genetic variation within tissues and peripheral blood mononuclear cells (PBMC) from two simian immunodeficiency virus (SIV)-infected macaques was analyzed. The products of PCR amplification of two regions, region 1 (SIV V1 region) and region 2 (region corresponding to the human immunodeficiency virus V3 cysteine loop and part of the C3 region immediately downstream), of the SIV envelope were examined for single-stranded conformation polymorphism followed by sequence analysis of selected clones. The V1 region of the SIV envelope of viruses present within lymphoid tissues displayed extensive heterogeneity, while viral populations within the PBMC and brain appeared to be less variable. Region 2 heterogeneity in both animals was generally confined to three residues in a tissue-specific manner. In addition, virus from the brains of both animals appeared to be distinct compared with viruses present in other tissues and PBMC of the same animal, both in the pattern of PCR-single-stranded conformation polymorphism SCP and in the sequence of region 2. These studies revealed that the tissues of SIV-infected macaques were a reservoir for viral variants distinct from those seen in PBMC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151778      PMCID: PMC236803     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  PCR-SSCP: a method for detection of mutations.

Authors:  K Hayashi
Journal:  Genet Anal Tech Appl       Date:  1992-06

2.  Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

Authors:  P Westervelt; H E Gendelman; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques.

Authors:  P R Johnson; T E Hamm; S Goldstein; S Kitov; V M Hirsch
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

4.  Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.

Authors:  J Overbaugh; L M Rudensey; M D Papenhausen; R E Benveniste; W R Morton
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease.

Authors:  S Pang; H V Vinters; T Akashi; W A O'Brien; I S Chen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

6.  Sequence variation in the env gene of simian immunodeficiency virus recovered from immunized macaques is predominantly in the V1 region.

Authors:  N Almond; A Jenkins; A B Heath; P Kitchin
Journal:  J Gen Virol       Date:  1993-05       Impact factor: 3.891

7.  Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues.

Authors:  V M Hirsch; P M Zack; A P Vogel; P R Johnson
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

8.  Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry.

Authors:  K Mori; D J Ringler; R C Desrosiers
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

10.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

View more
  16 in total

1.  Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology.

Authors:  Maria F Chen; Susan Westmoreland; Elena V Ryzhova; Julio Martín-García; Samantha S Soldan; Andrew Lackner; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

2.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia.

Authors:  V M Hirsch; G Dapolito; A Hahn; J Lifson; D Montefiori; C R Brown; R Goeken
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease.

Authors:  M A Rey-Cuillé; J L Berthier; M C Bomsel-Demontoy; Y Chaduc; L Montagnier; A G Hovanessian; L A Chakrabarti
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes.

Authors:  B J Campbell; V M Hirsch
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia.

Authors:  D Watry; T E Lane; M Streb; H S Fox
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

8.  Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model.

Authors:  A Radaelli; G Kraus; A Schmidt; P Badel; J McClure; S L Hu; W Morton; C De Giuli Morghen; F Wong-Staal; D Looney
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.

Authors:  Houman Dehghani; Bridget A Puffer; Robert W Doms; Vanessa M Hirsch
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy.

Authors:  I Nájera; A Holguín; M E Quiñones-Mateu; M A Muñoz-Fernández; R Nájera; C López-Galíndez; E Domingo
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.